Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells

Cancer Research

Volumn 59, Issue 1, 1999, Pages 80-84

  Aboagye, Eric O ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; PHOSPHATIDYLCHOLINE;

ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE; PHENOTYPE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION;

BREAST; CELL LINE; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; CHOLINE; EPITHELIAL CELLS; FEMALE; HUMANS; PHOSPHOLIPIDS;

EID: 0032893756     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cullis, P. R., and Hope, M. J. Physical properties and functional roles of lipids in membranes. In: D. E. Vance and J. Vance (ed.), Biochemistry of Lipids, Lipoproteins and Membranes, pp. 1-41. Amsterdam: Elsevier Science Publishers, 1991.
2. Mountford, C. E., and Wright, L. C. Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model. Trends Biochem. Sci., 13: 172-177, 1988.
3. Cuadrado, A., Carnero, A., Dolfi, F., Jimenez, B., and Lacal, J. C. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene, 8: 2959-2968, 1993.
4. Exton, J. H. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta, 1212: 26-42, 1994.
5. Pelech, S. L., and Vance, D. E. Signal transduction via phosphatidylcholine cycles. Trends Biochem. Sci., 14: 28-30, 1989.
6. Cai, H., Erhardt, P., Troppmair, J., Diaz-Meco, M. T., Sithanandam, G., Rapp, U. R., Moscat, J., and Cooper, G. M. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol. Cell. Biol., 13: 7645-7651, 1993.
7. Exton, J. H. Cell signalling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases. Eur. J. Biochem., 243: 10-20, 1997.
8. Carnero, A., Cuadrado, A., del Peso, L., and Lacal, J. C. Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells. Oncogene, 9: 1387-1395, 1994.
9. Ratnam, S., and Kent, C. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch. Biochem. Biophys., 323: 313-322, 1995.
10. Mackinnon, W. B., Barry, P. A., Malycha, P. L., Gillett, D. L., Russell, P., Lean, C. L., Doran, S. T., Barraclough, B. H., Bilous, M., and Mountford, C. Fine-needle biopsy specimen of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology, 204: 661-666, 1997.
11. Podo, F. Detection of phosphatidylcholine specific phospholipase C in NIH-3T3 fibroblast and H-ras transformants: NMR and immunochemical studies. Anticancer Res., 19: 1399-1412, 1996.
12. Ruiz-Cabello, J., and Cohen, J. S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed., 5: 226-233, 1992.
13. Rutter, A., Mackinnon, W. B., Huschtscha, L. I., and Mountford, C. E. A proton magnetic resonance spectroscopy study of aging and transformed human fibroblasts. Exp. Gerontol., 31: 669-686, 1996.
14. Ting, Y-L. T., Sherr, D., and Degani, H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res., 16: 1381-1388, 1996.
15. Stampfer, M. R., and Bartley, J. C. Induction of transformation in continuous cell lines from normal human mammary epithelial cells alter exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA, 82: 2394-2398, 1985.
16. Pierce, J. H., Arnstein, P., DiMarco, E., Artrip, J., Kraus, M. H., Lonardo, F., DiFiore, P. P., and Aaronson, S. A. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene, 6: 1189-1194, 1991.
17. Thompson, E. W., Torri, J., Sabol, M., Sommers, C. L., Byers, S., Valverius, E. M., Martin, G. R., Lippman, M. E., Stampfer, M. R., and Dickson, R. B. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis, 12: 181-194, 1994.
18. Valverius, E., Bates, S. E., Stampfer, M., Clark, R., McCormick, F., Salomon, D. S., Lippman, M. E., and Dickson, R. B. Transforming growth factor α and its receptor in human mammary epithelial cells: modulation of epidermal growth factor receptor function with oncogenic transformation. Mol. Endocrinol., 3: 203-214, 1989.
19. Smith, L. M., Birrer, M. J., Stampfer, M. R., and Brown, P. H. Breast cancer cells have lower activating protein I transcription factor activity than normal mammary epithelial cells. Cancer Res., 57: 3046-3054, 1997.
20. Stampfer, M. R., Bodnar, A., Garbe, J., Wong, M., Pan, A., Villeponteau, B., and Yaswen, P. Gradual phenolypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol. Biol. Cell., 8: 2391-2405, 1997.
21. Stampfer, M. R. Isolation and growth of human mammary epithelial cells. J. Tissue Culture Methods, 9: 107-116, 1985.
22. Stampfer, M. R., and Yaswen, P. Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation. Cancer Surv., 18: 7-34, 1994.
23. Paine, T. M., Soule, H. D., Pauley, R. J., and Dawson, P. J. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int. J. Cancer, 50: 463-473, 1992.
24. Plumb, J. A., Milroy, R., and Kaye, S. B. Effects of pH dependence of 3-(4.5-dimethylthiazole-2-yl)-2.5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49: 4435-4440, 1989.
25. Negendank, W. Studies of human tumors by MRS: a review. NMR Biomed., 5: 303-324, 1992.
26. Smith, T. A. D., Eccles, S., Ormerod, M. G., Tombs, A. J., Titley, J. C., and Leach, M. O. The phosphocholine and glycerophosphocholine content of oestrogen-sensitive rat mammary tumor correlates strongly with growth rate. Br. J. Cancer. 64: 821-826, 1991.
27. Dickson, R. B., Salomon, D. S., and Lippman, M. E. Tyrosine kinase receptor-nuclear protooncogene interaction in breast cancer. Cancer Treat. Res., 61: 249-273, 1992.
28. Beckman, M. W., Niederacher, D., Schnurch, H. G., Gueslerson, B. A., and Bender, H. G. Multistep carcinogenesis of breast cancer and tumor heterogeneity. J. Mol. Med., 1997: 429-437, 1993.
29. Adnane, J., Gaudray, P., Simon-Lafontaine, J., Jeanteur, P., and Theillet, C. Protooncogene amplification and breast cancer phenotype. Oncogene, 4: 1389-1395, 1989.
30. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
31. de Cremoux, P., Gauville, C., Closson, V., Linares, G., Calvo, F., Tavitian, A., and Olofsson, B. EGF modulation of the ras-related rhoB gene expression in human breast cancer cell lines. Int. J. Cancer. 59: 408-415, 1994.
32. Daly, R. J., Binder, M. D., and Sutherland, R. L. Overexpression of the Grb gene in human breast cancer cell lines. Oncogene, 9: 2723-2727, 1994.
33. Tadokoro, K., Ishidate, K., and Nakazawa, Y. Evidence for the existence of isozymes of choline kinase and their selective induction in 3-methylcholanthrene- or carbon tetrachloride-treated rat liver. Biochim. Biophys. Acta, 835: 501-513, 1985.